Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | WRN | Q14191 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | GSK3A | P49840 | 1/20 | 0.30 |
| ▸ | GSK3B | P49841 | 1/20 | 0.30 |
| ▸ | MGLL | Q99685 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL181744 | 1.00 | ALDH1A1 (0.34) | ALDH1A1CYP1A2HPGDCYP2C19BLM | |
| SCHEMBL28102949 | 0.95 | BACE1 (0.36) | ALDH1A1CYP1A2HPGDCYP2C19BLM | |
| Carbimide SCHEMBL28226102 | 0.94 | ALDH1A1 (0.31) | ALDH1A1CYP1A2HPGDCYP2C19BLM | |
| SCHEMBL4965543 | 0.91 | ALDH1A1 (0.31) | ALDH1A1CYP1A2HPGDCYP2C19BLM | |
| SCHEMBL5578691 | 0.91 | ALDH1A1 (0.31) | ALDH1A1CYP1A2HPGDCYP2C19BLM | |
| SCHEMBL28349186 | 0.91 | ALDH1A1 (0.31) | ALDH1A1CYP1A2HPGDCYP2C19BLM | |
| SCHEMBL22650155 | 0.90 | ALDH1A1 (0.37) | ALDH1A1CYP1A2HPGDCYP2C19BLM | |
| SCHEMBL28090625 | 0.88 | — | — | |
| SCHEMBL16552323 | 0.88 | HTR1A (0.33) | LMNAMGLL | |
| SCHEMBL9892471 | 0.88 | HTR1A (0.33) | LMNAMGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 28909 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4746921-A1 | DRUG CONJUGATES OF IMIDAZOQUINOLINE AMINE DERIVATIVES, COMPOSITIONS AND METHODS THEREOF | Canwell Biotech Limited (CN) | 2026-05-27 | — | — | EP | claimed |
| CN-122071700-A | Nanobody drug delivery system based on DNA paper folding technology | 中国人民解放军军事科学院军事医学研究院 | 2026-05-22 | — | — | CN | claimed |
| CN-122074047-A | Amyloid Precursor Protein (APP) RNAi agents | 伊莱利利公司 | 2026-05-22 | — | — | CN | claimed |
| WO-2026105128-A1 | MESO-2,3-DIMERCAPTOSUCCINIC ACID (DMSA)-CONJUGATED NUCLEOTIDE-BASED AGENTS HAVING IMPROVED DELIVERY TO KIDNEY TISSUE | Sheba Impact Ltd. (IL) | 2026-05-21 | — | — | WO | claimed |
| US-20260137821-A1 | PEPTIDE STRUCTURE TARGETING CARBONIC DEHYDROGENASE IX AND USE THEREOF | C-BIOMEX CO., LTD. (KR) | 2026-05-21 | — | — | US | claimed |
| US-20260139073-A1 | Antigen Binding Proteins | GLAXO GROUP LIMITED (GB) | 2026-05-21 | — | — | US | claimed |
| CN-122070360-A | Use of non-porous, non-magnetic microparticles as a kit for activation and proliferation of human T lymphocytes | 生物细胞再生有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122055156-A | (R) -N-ethyl-5-fluoro-N-isopropyl-2- ((5- (2- (6- ((2-methoxyethyl) (methyl) amino) -2-methyl-hex-3-yl) -2, 6-diazaspiro [3.4] oct-6-yl) -1,2, 4-triazin-6-yl) oxy) benzamide, formulations and dosing regimens for treating cancer | 詹森药业有限公司 | 2026-05-15 | — | — | CN | claimed |
| US-20260132397-A1 | IMMOBILIZED ENZYMES FOR BIOELECTROCATALYSIS | ANODYNE CHEMISTRIES INC (CA) | 2026-05-14 | — | — | US | claimed |
| CN-115819588-B | Novel anti-CD 19 antibodies | 上海药明生物技术有限公司 | 2026-05-12 | — | — | CN | claimed |
| WO-1990011779-A1 | HETEROCONJUGATES | MEDICAL RESEARCH COUNCIL (GB) | 1990-10-18 | — | — | WO | claimed |
| EP-0310413-A2 | Immobilized antibodies | NIHON CHEMICAL RESEARCH KABUSHIKI KAISHA also known as JCR PHARMACEUTICALS CO., LTD (JP) | 1989-04-05 | — | — | EP | claimed |
| EP-0306943-A2 | Immunconjugates joined by thioether bonds having reduced toxicity and improved selectivity | NEORX CORPORATION (US) | 1989-03-15 | — | — | EP | claimed |
| EP-0306309-A2 | Monoclonal antibodies recognizing alpha-hANP and corresponding hybridomas, their preparation and use | SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. (JP) | 1989-03-08 | — | — | EP | claimed |
| EP-0251494-A2 | Therapeutic or radiodiagnostic compound | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 1988-01-07 | — | — | EP | claimed |
| US-4657853-A | Immunoassays utilizing covalent conjugates of polymerized enzyme and antibody | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-04-14 | — | — | US | claimed |
| EP-0196669-A2 | Improved method of conjugating metallothionein to biologically active molecules | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1986-10-08 | — | — | EP | claimed |
| US-4608246-A | Testing for a blood group immunological reaction | IMMUCOR, INC. (US) | 1986-08-26 | — | — | US | claimed |
| EP-0184710-A2 | Magnetic microspheres | BAYER AG (DE) | 1986-06-18 | — | — | EP | claimed |
| EP-0175560-A2 | Immunoassays utilizing covalent conjugates of polymerized enzyme and antibody | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-03-26 | — | — | EP | claimed |